SEZanne: A phase 2 randomized, open-label, multicenter study to evaluate the optimal dose, safety, and efficacy of ABBV-706 in combination with atezolizumab (atezo) versus standard of care (SOC) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC).

  • Cuppens, Kristof; 
  • Byers, Lauren Averett; 
  • Goto, Yasushi; 
  • Ardizzoni, Andrea; 
  • Paz-Ares, Luis G.; 
  • ... Lee, Se-Hoon; 
  • 외 11명
Citations

WEB OF SCIENCE

1
제목
SEZanne: A phase 2 randomized, open-label, multicenter study to evaluate the optimal dose, safety, and efficacy of ABBV-706 in combination with atezolizumab (atezo) versus standard of care (SOC) in patients (pts) with previously untreated extensive-stage (ES) small cell lung cancer (SCLC).
저자
Cuppens, Kristof; Byers, Lauren Averett; Goto, Yasushi; Ardizzoni, Andrea; Paz-Ares, Luis G.; Zhou, Caicun; Dowlati, Afshin; Cooper, Alissa Jamie; Bar, Jair; Lee, Se-Hoon; Jahchan, Nadine; Zhao, Ye; Meiman, Darius; Fang, Fang; Rivell, Guillermo; Palenski, Tammy; Chiang, Anne C.
DOI
10.1200/JCO.2026.44.16_suppl.TPS8135
발행일
2026-06-01
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
44
호
16_SUPPL
페이지
TPS8135 ~ TPS8135